AMLX · Forms 3, 4, 5

Insider trades at Amylyx Pharmaceuticals, Inc.

1 insider sold $831K of Amylyx Pharmaceuticals, Inc. stock on the open market in the last 30 days.

Every Form 3, 4 and 5 filed for Amylyx Pharmaceuticals, Inc. (AMLX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
George M Milne JrDirectorSell (10b5-1 plan)30,000$27.70$831KForm 4
Camille L BedrosianChief Medical OfficerSell7,947$32.21$256KForm 4
Camille L BedrosianChief Medical OfficerSell2,081$33.09$69KForm 4
James M FratesChief Financial OfficerSell9,768$32.27$315KForm 4
James M FratesChief Financial OfficerSell1,042$33.23$35KForm 4
Gina MazzarielloChief Legal OfficerSell9,525$32.46$309KForm 4
Gina MazzarielloChief Legal OfficerSell11$33.34$367Form 4
Justin B. KleeCo-Chief Executive OfficerSell29,025$32.13$933KForm 4
Justin B. KleeCo-Chief Executive OfficerSell1,439$33.16$48KForm 4
Joshua B CohenCo-Chief Executive OfficerSell29,545$32.16$950KForm 4
Joshua B CohenCo-Chief Executive OfficerSell919$33.15$30KForm 4
Karen FirestoneDirectorOption exercise25,000$1.76$44KForm 4
Karen FirestoneDirectorOption exercise25,000$5.05$126KForm 4
James M FratesChief Financial OfficerAward22,807Form 4
Justin B. KleeCo-Chief Executive OfficerAward60,039Form 4
Gina MazzarielloChief Legal OfficerAward21,284Form 4
Camille L BedrosianChief Medical OfficerAward22,807Form 4
Joshua B CohenCo-Chief Executive OfficerAward60,039Form 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.